Multipathogen adoptive immunotherapy for post-transplant virus-associated diseases [ 2016 - 2019 ]

Research Grant

Researchers: Prof Rajiv Khanna (Principal investigator) ,  A/Pr Daniel Chambers ,  A/Pr Scott Campbell ,  Dr Corey Smith

Brief description This project is aiming to develop an “off-the-shelf” killer T cell therapy for transplant patients and patients with virus-associated malignancies. This therapy is based on a novel technology developed by our group which allows rapid expansion of killer T cells directed against multiple viruses.

Funding Amount $AUD 1,100,873.41

Funding Scheme Project Grants

Notes Standard Project Grant